{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:55:14Z","timestamp":1781639714163,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002631","name":"Gachon University","doi-asserted-by":"crossref","award":["GCU-2020-202005390001"],"award-info":[{"award-number":["GCU-2020-202005390001"]}],"id":[{"id":"10.13039\/501100002631","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In this study, we evaluated the effectiveness of EZFluence (EZF), an automated fluence optimization tool, in planning breast cancer radiotherapy by comparing its dosimetric performance with that of three-dimensional conformal radiotherapy (3D-CRT), intensity-modulated radiation therapy (IMRT), and volumetric-modulated arc therapy (VMAT). Specifically, we aimed to determine whether EZF can enhance target coverage, minimize dose to organs at risk, and improve planning efficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective analysis included 35 patients who received whole-breast irradiation for left-sided breast cancer. Treatment plans were generated using 3D-CRT, IMRT, VMAT, and EZF-based forward-planned field-in-field techniques. Dosimetric parameters, including planning target volume coverage, cardiac exposure, left anterior descending artery dose, lung dose, and contralateral tissue dose, were analyzed. Planning efficiency was assessed by comparing the monitor units and planning time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      EZF demonstrated significantly superior dose homogeneity and a lower delivered maximum dose compared with 3D-CRT and IMRT. Although VMAT provided the highest planning target volume V\n                      <jats:sub>95<\/jats:sub>\n                      , EZF maintained comparable target coverage with significantly reduced high-dose regions. Additionally, EZF achieved a lower mean heart dose compared with 3D-CRT and IMRT. While VMAT offered superior high-dose cardiac sparing, EZF minimized low-dose cardiac spread and significantly reduced the mean lung dose and low-dose volumes of the left lung compared with IMRT and VMAT. The mean doses to the contralateral breast with 3D-CRT and EZF were less than 1\u00a0Gy, whereas those when using IMRT and VMAT exceeded 1\u00a0Gy. Regarding efficiency, EZF required fewer monitor units than did IMRT and VMAT, and its automated planning process reduced inter-planner variability.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>EZF demonstrated significant potential as an innovative approach in breast cancer radiotherapy, providing comparable target coverage with enhanced sparing of organs at risk and without unnecessary contralateral dose. Its automated fluence optimization enhanced planning efficiency by simplifying planning and reducing variability. These findings support the integration of EZF into routine clinical practice to optimize radiotherapy delivery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-026-02815-y","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:44:14Z","timestamp":1772642654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Automated fluence optimization in breast cancer radiotherapy: balancing dosimetric quality, organ-at-risk sparing, and workflow efficiency"],"prefix":"10.1186","volume":"21","author":[{"given":"Young Eun","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Back","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KiHoon","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"2815_CR1","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u2009\u2013\u200949.","DOI":"10.3322\/caac.21660"},{"issue":"9804","key":"2815_CR2","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"S Darby","year":"2011","unstructured":"Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet (London England). 2011;378(9804):1707\u201316.","journal-title":"Lancet (London England)"},{"issue":"9503","key":"2815_CR3","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"M Clarke","year":"2005","unstructured":"Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (London England). 2005;366(9503):2087\u2013106.","journal-title":"Lancet (London England)"},{"issue":"3","key":"2815_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.radonc.2006.12.008","volume":"82","author":"E Donovan","year":"2007","unstructured":"Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hanson J, et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol. 2007;82(3):254\u201364.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2815_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.radonc.2014.10.004","volume":"114","author":"T Grantzau","year":"2015","unstructured":"Grantzau T, Overgaard J. Risk of second non-breast cancer after radiotherapy for breast cancer: A systematic review and meta-analysis of 762,468 patients. Radiother Oncol. 2015;114(1):56\u201365.","journal-title":"Radiother Oncol"},{"issue":"3","key":"2815_CR6","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.ijrobp.2007.06.060","volume":"69","author":"WA Beckham","year":"2007","unstructured":"Beckham WA, Popescu CC, Patenaude VV, Wai ES, Olivotto IA. Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer? Int J Radiat Oncol Biol Phys. 2007;69(3):918\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2815_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clon.2004.08.008","volume":"17","author":"CE Coles","year":"2005","unstructured":"Coles CE, Moody AM, Wilson CB, Burnet NG. Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiation. Part I\u2013normal tissue complications. Clin Oncol (R Coll Radiol (G B)). 2005;17(1):16\u201324.","journal-title":"Clin Oncol (R Coll Radiol (G B))"},{"issue":"1","key":"2815_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13014-019-1363-4","volume":"14","author":"D Karpf","year":"2019","unstructured":"Karpf D, Sakka M, Metzger M, Grabenbauer GG. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage. Radiation Oncol (London England). 2019;14(1):156.","journal-title":"Radiation Oncol (London England)"},{"issue":"4","key":"2815_CR9","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.meddos.2020.05.004","volume":"45","author":"Y Xie","year":"2020","unstructured":"Xie Y, Bourgeois D, Guo B, Zhang R. Comparison of conventional and advanced radiotherapy techniques for left-sided breast cancer after breast conserving surgery. Med Dosim. 2020;45(4):e9\u201316.","journal-title":"Med Dosim"},{"issue":"1","key":"2815_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0360-3016(03)00073-7","volume":"56","author":"EJ Hall","year":"2003","unstructured":"Hall EJ, Wuu C-S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiation Oncology*Biology*Physics. 2003;56(1):83\u20138.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"issue":"4","key":"2815_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.semradonc.2022.06.004","volume":"32","author":"D Nguyen","year":"2022","unstructured":"Nguyen D, Lin M-H, Sher D, Lu W, Jia X, Jiang S. Advances in Automated Treatment Planning. Semin Radiat Oncol. 2022;32(4):343\u201350.","journal-title":"Semin Radiat Oncol"},{"key":"2815_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.phro.2022.06.009","volume":"23","author":"PG Esposito","year":"2022","unstructured":"Esposito PG, Castriconi R, Mangili P, Broggi S, Fodor A, Pasetti M, et al. Knowledge-based automatic plan optimization for left-sided whole breast tomotherapy. Phys imaging radiation Oncol. 2022;23:54\u20139.","journal-title":"Phys imaging radiation Oncol"},{"issue":"1","key":"2815_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13014-023-02364-8","volume":"18","author":"L Marrazzo","year":"2023","unstructured":"Marrazzo L, Redapi L, Pellegrini R, Voet P, Meattini I, Arilli C, et al. Fully automated volumetric modulated arc therapy technique for radiation therapy of locally advanced breast cancer. Radiat Oncol. 2023;18(1):176.","journal-title":"Radiat Oncol"},{"issue":"1","key":"2815_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13014-025-02634-7","volume":"20","author":"Z Hou","year":"2025","unstructured":"Hou Z, Qin L, Gu J, Liu Z, Liu J, Zhang Y, et al. Deep learning-powered radiotherapy dose prediction: clinical insights from 622 patients across multiple sites tumor at a single institution. Radiat Oncol. 2025;20(1):80.","journal-title":"Radiat Oncol"},{"key":"2815_CR15","doi-asserted-by":"crossref","unstructured":"Marrazzo L, Chil\u00e0 D, Vanore I, Pellegrini R, Voet P, Di Cataldo V, et al. Planning automation for treatment techniques comparison and robustness analysis: tangential intensity modulated radiation therapy and volumetric modulated arc therapy for whole breast irradiation. Adv Radiation Oncol. 2025;10(3).","DOI":"10.1016\/j.adro.2025.101719"},{"issue":"4","key":"2815_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/acm2.13228","volume":"22","author":"I Dragojevi\u0107","year":"2021","unstructured":"Dragojevi\u0107 I, Hoisak JDP, Mansy GJ, Rahn DA, Manger RP. Assessing the performance of an automated breast treatment planning software. J Appl Clin Med Phys. 2021;22(4):115\u201320.","journal-title":"J Appl Clin Med Phys"},{"issue":"4","key":"2815_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.meddos.2018.12.001","volume":"44","author":"T Yoder","year":"2019","unstructured":"Yoder T, Hsia AT, Xu Z, Stessin A, Ryu S. Usefulness of EZFluence software for radiotherapy planning of breast cancer treatment. Med dosimetry: official J Am Association Med Dosimetrists. 2019;44(4):339\u201343.","journal-title":"Med dosimetry: official J Am Association Med Dosimetrists"},{"key":"2815_CR18","unstructured":"Ervick CJ. A Quantitative study of correlations between patient load with the usage of artificial intelligence treatment planning tools (auto planning, adaptive RT, clear check, deformable dose, auto-contouring, EZFluence, etc.) A United States context. Grand Valley State University; 2021."},{"key":"2815_CR19","unstructured":"Loomis J. Effects of EZFluence planning software on dosimetric parameter compliance for early-stage breast cancer. Grand Valley State University; 2022."},{"issue":"2","key":"2815_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ijrobp.2007.12.058","volume":"72","author":"CW Taylor","year":"2008","unstructured":"Taylor CW, Povall JM, McGale P, Nisbet A, Dodwell D, Smith JT, et al. Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys. 2008;72(2):501\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2815_CR21","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ijrobp.2022.07.2320","volume":"114","author":"FA Vicini","year":"2022","unstructured":"Vicini FA, Winter K, Freedman GM, Arthur DW, Hayman JA, Rosenstein BS, et al. NRG RTOG 1005: A Phase III Trial of Hypo Fractionated Whole Breast Irradiation with Concurrent Boost vs. Conventional Whole Breast Irradiation Plus Sequential Boost Following Lumpectomy for High Risk Early-Stage Breast Cancer. Int J Radiat Oncol Biol Phys. 2022;114(3):S1.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2815_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.meddos.2016.06.005","volume":"41","author":"K Balaji","year":"2016","unstructured":"Balaji K, Subramanian B, Yadav P, Anu Radha C, Ramasubramanian V. Radiation therapy for breast cancer: Literature review. Med Dosim. 2016;41(3):253\u20137.","journal-title":"Med Dosim"},{"key":"2815_CR23","doi-asserted-by":"publisher","first-page":"1195266","DOI":"10.3389\/fonc.2023.1195266","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, Shen J, Gu P, Wang Z. Recent advances progress in radiotherapy for breast cancer after breast-conserving surgery: a review. Front Oncol. 2023;13:1195266.","journal-title":"Front Oncol"},{"key":"2815_CR24","doi-asserted-by":"crossref","unstructured":"Kendall R, Robinson T, Reed V, Kanke J, Sosa A, Nelson C, et al. Why is volumetric modulated arc therapy not considered the standard of care for locoregional radiation therapy for breast cancer patients? Adv Radiation Oncol. 2025;10(5).","DOI":"10.1016\/j.adro.2025.101728"},{"issue":"914","key":"2815_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1259\/bjr\/11764177","volume":"77","author":"K Venables","year":"2004","unstructured":"Venables K, Miles EA, Deighton A, Aird EGA, Hoskin PJ, Barrett J, et al. Irradiation of the heart during tangential breast treatment: A study within the START trial. Br J Radiol. 2004;77(914):137\u201342.","journal-title":"Br J Radiol"},{"issue":"3","key":"2815_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.canrad.2020.09.003","volume":"25","author":"Z Naimi","year":"2021","unstructured":"Naimi Z, Moujahed R, Neji H, Yahyaoui J, Hamdoun A, Bohli M, et al. Cardiac substructures exposure in left-sided breast cancer radiotherapy: Is the mean heart dose a reliable predictor of cardiac toxicity? Cancer\/Radioth\u00e9rapie. 2021;25(3):229\u201336.","journal-title":"Cancer\/Radioth\u00e9rapie"},{"issue":"3, Supplement","key":"2815_CR27","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.ijrobp.2009.04.093","volume":"76","author":"G Gagliardi","year":"2010","unstructured":"Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, Allen AM, et al. Radiation Dose\u2013Volume Effects in the Heart. Int J Radiation Oncology*Biology*Physics. 2010;76(3, Supplement):S77\u201385.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"issue":"3","key":"2815_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.radonc.2008.07.021","volume":"89","author":"A Fogliata","year":"2008","unstructured":"Fogliata A, Clivio A, Nicolini G, Vanetti E, Cozzi L. Intensity modulation with photons for benign intracranial tumours: a planning comparison of volumetric single arc, helical arc and fixed gantry techniques. Radiotherapy oncology: J Eur Soc Therapeutic Radiol Oncol. 2008;89(3):254\u201362.","journal-title":"Radiotherapy oncology: J Eur Soc Therapeutic Radiol Oncol"},{"issue":"3","key":"2815_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.14316\/pmp.2021.32.3.70","volume":"32","author":"G Kumar","year":"2021","unstructured":"Kumar G, Bhushan M, Kumar L, Kishore V, Raman K, Kumar P, et al. Dosimetric Evaluation of Low-Dose Spillage Volumes for Head and Neck Cancer Using Intensity-Modulated Radiation Therapy and Volumetric Modulated Arc Therapy Treatment Techniques. Prog Med Phys. 2021;32(3):70\u201381.","journal-title":"Prog Med Phys"},{"issue":"3","key":"2815_CR30","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.ijrobp.2007.06.060","volume":"69","author":"WA Beckham","year":"2007","unstructured":"Beckham WA, Popescu CC, Patenaude VV, Wai ES, Olivotto IA. Is Multibeam IMRT Better Than Standard Treatment for Patients With Left-Sided Breast Cancer? Int J Radiation Oncology*Biology*Physics. 2007;69(3):918\u201324.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"issue":"4","key":"2815_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1667\/RADE-23-00014.1","volume":"200","author":"GP Watt","year":"2023","unstructured":"Watt GP, Smith SA, Howell RM, P\u00e9rez-And\u00fajar A, Reiner AS, Cervi\u00f1o L, et al. Trends in Radiation Dose to the Contralateral Breast During Breast Cancer Radiation Therapy. Radiat Res. 2023;200(4):331\u20139.","journal-title":"Radiat Res"},{"issue":"4","key":"2815_CR32","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.ijrobp.2008.02.040","volume":"72","author":"M Stovall","year":"2008","unstructured":"Stovall M, Smith SA, Langholz BM, Boice JD Jr., Shore RE, Andersson M, et al. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008;72(4):1021\u201330.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2815_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00066-018-1384-1","volume":"195","author":"C Simonetto","year":"2019","unstructured":"Simonetto C, Rennau H, Remmele J, Sebb S, Kundr\u00e1t P, Eidem\u00fcller M, et al. Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al]. 2019;195(1):32\u201342.","journal-title":"Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al]"},{"key":"2815_CR34","first-page":"23","volume":"80","author":"R Yamauchi","year":"2020","unstructured":"Yamauchi R, Mizuno N, Itazawa T, Kawamori J. The influence of respiratory motion on dose distribution in accelerated partial breast irradiation using volumetric modulated arc therapy. Phys medica: PM : Int J devoted Appl Phys Med biology : official J Italian Association Biomedical Phys (AIFB). 2020;80:23\u201333.","journal-title":"Phys medica: PM : Int J devoted Appl Phys Med biology : official J Italian Association Biomedical Phys (AIFB)"},{"issue":"4","key":"2815_CR35","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.ijrobp.2003.07.005","volume":"58","author":"RC Frazier","year":"2004","unstructured":"Frazier RC, Vicini FA, Sharpe MB, Yan D, Fayad J, Baglan KL, et al. Impact of breathing motion on whole breast radiotherapy: a dosimetric analysis using active breathing control. Int J Radiat Oncol Biol Phys. 2004;58(4):1041\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2815_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.21873\/anticanres.14791","volume":"41","author":"YE Choi","year":"2021","unstructured":"Choi YE, Sung K, Dong KS, Kim HJ, Lim YK. Dosimetric Impact of Respiratory Motion During Breast Intensity-modulated Radiation Therapy Using Four-dimensional Dose Calculations. Anticancer Res. 2021;41(1):417\u201327.","journal-title":"Anticancer Res"},{"issue":"1","key":"2815_CR37","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s41598-022-05538-8","volume":"12","author":"N Mizuno","year":"2022","unstructured":"Mizuno N, Yamauchi R, Kawamori J, Itazawa T, Shimbo M, Nishimura K, et al. Evaluation of robustness in hybrid intensity-modulated radiation therapy plans generated by commercial software for automated breast planning. Sci Rep. 2022;12(1):1418.","journal-title":"Sci Rep"},{"key":"2815_CR38","doi-asserted-by":"publisher","first-page":"100764","DOI":"10.1016\/j.ctro.2024.100764","volume":"46","author":"I Ratosa","year":"2024","unstructured":"Ratosa I, Montero A, Ciervide R, Alvarez B, Garc\u00eda-Aranda M, Valero J, et al. Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results. Clin translational radiation Oncol. 2024;46:100764.","journal-title":"Clin translational radiation Oncol"},{"issue":"2","key":"2815_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijrobp.2025.02.003","volume":"122","author":"M Dzhugashvili","year":"2025","unstructured":"Dzhugashvili M, Serradilla A, Fern\u00e1ndez-Ibiza J, Garc\u00eda G, Malinochka KM, Torres L, et al. Ultrahypofractionation and Simultaneous Integrated Boost in Breast Cancer: Early Side Effects Analysis. Int J Radiat Oncol Biol Phys. 2025;122(2):241\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"2815_CR40","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1080\/0284186X.2023.2267170","volume":"62","author":"LM Sauvage","year":"2023","unstructured":"Sauvage LM, Loap P, Vu-Bezin J, Cao K, Kissel M, Bringer S, et al. Large scale experience of two ultrahypofractionated 5 fractions regimes after breast conserving surgery from a single centre. Acta Oncol (Stockholm Sweden). 2023;62(12):1791\u20137.","journal-title":"Acta Oncol (Stockholm Sweden)"},{"key":"2815_CR41","doi-asserted-by":"publisher","first-page":"e2200127","DOI":"10.1200\/GO.22.00127","volume":"9","author":"M Mushonga","year":"2023","unstructured":"Mushonga M, Weiss J, Liu ZA, Nyakabau AM, Mohamad O, Tawk B, et al. Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: Results of an International Survey. JCO global Oncol. 2023;9:e2200127.","journal-title":"JCO global Oncol"},{"key":"2815_CR42","unstructured":"Woodburn BL. Using Radformation EZFluence software to simplify three field breast radiation therapy planning compared to field-in-field technique [Project]. Grand Valley State University; 2022."}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-026-02815-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02815-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02815-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:21:47Z","timestamp":1781637707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-026-02815-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2815"],"URL":"https:\/\/doi.org\/10.1186\/s13014-026-02815-y","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Gachon University Gil Medical Center Institutional Review Board (GFIRB2025-056), which waived the requirement for informed consent because of the study\u2019s retrospective design and use of de-identified data. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}